Literature DB >> 19093131

Pleural and pericardial morbidity after minimal access repair of pectus excavatum.

C Castellani1, A K Saxena, D Zebedin, M E Hoellwarth.   

Abstract

PURPOSE: The aim of this study was to evaluate the pleural and pericardial morbidity in patients that had undergone pectus excavatum corrections using minimal access repair of pectus excavatum (MARPE) at a single center.
MATERIALS AND METHODS: Data from patients after MARPE from 2000 to 2007 were prospectively collected. Patients with pneumothorax and pleural and pericardial effusions were identified.
RESULTS: One hundred eighty patients were corrected by MARPE. Eighty-four were identified to have pleural or pericardial morbidities. Pneumothorax was documented in 33 patients and five required placement of a chest tube. Pleural effusions were recorded in 53 and were found to recur in four patients. Drainage was necessary in 18 patients. Pericardial effusions were observed in five patients; in two cases, they were associated with recurring pleural effusions, suggesting postcardiomyotomy syndrome.
CONCLUSIONS: MARPE is associated with a high rate of pleural and pericardial morbidities, but only a small number requires interventions.

Entities:  

Mesh:

Year:  2008        PMID: 19093131     DOI: 10.1007/s00423-008-0448-6

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  26 in total

1.  Complications associated with the Nuss procedure: analysis of risk factors and suggested measures for prevention of complications.

Authors:  Hyung Joo Park; Seock Yeol Lee; Cheol Sae Lee
Journal:  J Pediatr Surg       Date:  2004-03       Impact factor: 2.545

2.  Major complications after minimally invasive repair of pectus excavatum: case reports.

Authors:  R L Moss; C T Albanese; M Reynolds
Journal:  J Pediatr Surg       Date:  2001-01       Impact factor: 2.545

3.  Minimally invasive repair of pectus excavatum - shifting the paradigm?

Authors:  C Petersen; J Leonhardt; M Duderstadt; M Karck; B M Ure
Journal:  Eur J Pediatr Surg       Date:  2006-04       Impact factor: 2.191

4.  Minimally invasive correction of pectus excavatum in adult patients.

Authors:  Johannes Schalamon; Stefan Pokall; Jana Windhaber; Michael E Hoellwarth
Journal:  J Thorac Cardiovasc Surg       Date:  2006-09       Impact factor: 5.209

5.  Experience and modification update for the minimally invasive Nuss technique for pectus excavatum repair in 303 patients.

Authors:  Daniel P Croitoru; Robert E Kelly; Michael J Goretsky; M Louise Lawson; Barbara Swoveland; Donald Nuss
Journal:  J Pediatr Surg       Date:  2002-03       Impact factor: 2.545

6.  Comparing minimally invasive funnel chest repair versus the conventional technique: an outcome analysis in children.

Authors:  Roland A Boehm; Oliver J Muensterer; Holger Till
Journal:  Plast Reconstr Surg       Date:  2004-09-01       Impact factor: 4.730

Review 7.  The postcardiac injury syndromes.

Authors:  A H Khan
Journal:  Clin Cardiol       Date:  1992-02       Impact factor: 2.882

8.  Review and discussion of the complications of minimally invasive pectus excavatum repair.

Authors:  D Nuss; D P Croitoru; R E Kelly; M J Goretsky; K J Nuss; T S Gustin
Journal:  Eur J Pediatr Surg       Date:  2002-08       Impact factor: 2.191

9.  Early complications of the Nuss procedure for pectus excavatum: a prospective study.

Authors:  Christoph Castellani; Johannes Schalamon; Amulya K Saxena; Michael E Höellwarth
Journal:  Pediatr Surg Int       Date:  2008-04-05       Impact factor: 1.827

10.  Postpericardiotomy syndrome after minimally invasive repair of pectus excavatum.

Authors:  Tobias Berberich; Frank-Martin Haecker; Beat Kehrer; Thomas O Erb; Joelle Günthard; Juerg Hammer; Peter M Jenny
Journal:  J Pediatr Surg       Date:  2004-11       Impact factor: 2.545

View more
  1 in total

1.  Exercise performance testing in patients with pectus excavatum before and after Nuss procedure.

Authors:  Christoph Castellani; J Windhaber; P H Schober; M E Hoellwarth
Journal:  Pediatr Surg Int       Date:  2010-06-08       Impact factor: 1.827

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.